Abstract
Glucose tolerance tests were performed on six hyperthyroid patients in the morning and afternoon before, and at the end of treatment with propranolol for 2 weeks. All six subjects showed normal glucose tolerance with a normal diurnal rhythm before treatment and this remained normal in five during treatment with propranolol, while one patient developed abnormal glucose tolerance and the diurnal variation was abolished. No change in insulin levels was noted in any of the patients either before or during treatment. Propranolol may cause deterioration in glucose tolerance in some subjects with hyperthyroidism and this possibility should not be overlooked.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cerasi E., Effendic S., Luft R. Role of adrenergic receptors in glucose-induced insulin secretion in man. Lancet. 1969 Aug 9;2(7615):301–302. doi: 10.1016/s0140-6736(69)90059-2. [DOI] [PubMed] [Google Scholar]
- HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HILL J. B., KESSLER G. An automated determination of glucose utilizing a glucose oxidase-peroxidase system. J Lab Clin Med. 1961 Jun;57:970–980. [PubMed] [Google Scholar]
- Hadden D. R., Montgomery D. A., Shanks R. G., Weaver J. A. Propranolol and iodine-131 in the management of thyrotoxicosis. Lancet. 1968 Oct 19;2(7573):852–854. doi: 10.1016/s0140-6736(68)91003-9. [DOI] [PubMed] [Google Scholar]
- Jarrett R. J., Baker I. A., Keen H., Oakley N. W. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening. Br Med J. 1972 Jan 22;1(5794):199–201. doi: 10.1136/bmj.1.5794.199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kreines K., Jett M., Knowles H. C., Jr Observations in hyperthyroidism of abnormal glucose tolerance and other traits related to diabetes mellitus. Diabetes. 1965 Nov;14(11):740–744. doi: 10.2337/diab.14.11.740. [DOI] [PubMed] [Google Scholar]
- Michie W., Hammer-Hodges D. W., Pegg C. A., Orr F. G., Bewsher P. D. Beta-blockade and partial thyroidectomy for thyrotoxicosis. Lancet. 1974 May 25;1(7865):1009–1011. doi: 10.1016/s0140-6736(74)90414-0. [DOI] [PubMed] [Google Scholar]
- Porte D., Jr Beta adrenergic stimulation of insulin release in man. Diabetes. 1967 Mar;16(3):150–155. doi: 10.2337/diab.16.3.150. [DOI] [PubMed] [Google Scholar]
- Shanks R. G., Hadden D. R., Lowe D. C., McDevitt D. G., Montgomery D. A. Controlled trial of propranolol in thyrotoxicosis. Lancet. 1969 May 17;1(7603):993–994. doi: 10.1016/s0140-6736(69)91797-8. [DOI] [PubMed] [Google Scholar]